Los Angeles CA
3-06-2023 7:44am

Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study

On Monday, March 6, 2023 the NIH announced a clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy grown-ups and found that it was safe and the vaccine produced both antibodies and responses from the cellular arm of the immune system. To read more visit: Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study.

By Anita Johnson-Brown

Photo: NIH

More News from Los Angeles
I'm interested
I disagree with this
This is unverified
Spam
Offensive